Document and Entity Information Document Type Document Quarterly Report Document Period End Date Document Transition Report Entity File Number Entity Registrant Name Entity Incorporation, State or Country Code Entity Tax Identification Number Entity Address, Address Line One Entity Address, City or Town Entity Address, State or Province Entity Address, Postal Zip Code City Area Code Local Phone Number Title of 12(b) Security Trading Symbol Security Exchange Name Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Entity Shell Company Entity Common Stock, Shares Outstanding Entity Central Index Key Current Fiscal Year End Date Document Fiscal Year Focus Document Fiscal Period Focus Amendment Flag INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS Statement [Table] Statement [Table] Statement [Line Items] Statement Assets [Abstract] ASSETS Assets, Current [Abstract] Current Assets: Cash and Cash Equivalents, at Carrying Value Cash and cash equivalents Short-term Investments Short-term deposit (Note 4) Nontrade Receivables, Current Other accounts receivable Prepaid Expense and Other Assets, Current Prepaid expenses and other current assets Assets, Current Total current assets Assets, Noncurrent [Abstract] Long-Term Assets: Prepaid Expense and Other Assets, Noncurrent Prepaid expenses and other long-term assets Operating Lease, Right-of-Use Asset Operating lease right of use asset (Note 6) Operating lease right of use asset Property, Plant and Equipment, Net Property and Equipment, Net Other Assets, Noncurrent Total Long-Term Assets Assets Total assets Liabilities and Equity [Abstract] LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT) Liabilities, Current [Abstract] Current Liabilities: Accounts Payable, Current Accounts payables Accrued Liabilities, Current Accrued expenses Operating Lease, Liability, Current Operating lease liability (Note 5) The amount represents the other accounts payable current. Other Accounts Payable Current Other accounts payables Liabilities, Current Total current liabilities Liabilities, Noncurrent [Abstract] Long-Term Liabilities: Operating Lease, Liability, Noncurrent Operating lease liability (Note 5) Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Share Value, Amount, Noncurrent Warrants liability (Note 6) Liabilities, Noncurrent Total long-term liabilities Liabilities Total liabilities Stockholders' Equity Attributable to Parent [Abstract] Stockholders' Equity: Common Stock, Value, Issued Stock capital: (Note 7) Common Stock of $0.00005 par value - Authorized: 100,000,000 shares September 30, 2023 and December 31, 2022 respectively; Issued and outstanding: 45,314,961 and 36,694,078 shares at September 30, 2023 and December 31, 2022 respectively. Additional Paid in Capital, Common Stock Additional paid-in-capital Treasury Stock, Common, Value Treasury stocks Retained Earnings (Accumulated Deficit) Accumulated deficit Accumulated deficit Stockholders' Equity Attributable to Parent Balance Balance Total stockholders' equity (deficit) Liabilities and Equity Total liabilities and stockholders' equity (deficit) Common Stock, Par or Stated Value Per Share Common Stock, par value (in dollars per share) Common Stock, Shares Authorized Common Stock, shares authorized Common Stock, Shares, Issued Common Stock, shares issued Common Stock, Shares, Outstanding Common Stock, shares outstanding INTERIM CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (UNAUDITED) Operating Expenses [Abstract] Operating expenses: Research and Development Expense Research and development, net General and Administrative Expense General and administrative Operating Income (Loss) Operating loss Represents the amount of financial expenses (income), net during the period. Financial Expenses Income Net Financial income (expenses), net Amount of expense (income) related to adjustment to fair value of warrant liability and stock issuance costs. Fair Value Adjustments Of Warrants And Stock Issuance Costs Gain on change in fair value of Warrants liability (Note 6) Net Income (Loss) Attributable to Parent Net loss Net loss Earnings Per Share, Basic Basic net loss per share from continuing operations Earnings Per Share, Diluted Diluted net loss per share from continuing operations Weighted Average Number of Shares Outstanding, Basic Weighted average number of shares outstanding used in computing basic net loss per share Weighted Average Number of Shares Outstanding, Diluted Weighted average number of shares outstanding used in computing diluted net loss per share STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY DEFICIT (UNAUDITED) Equity Components [Axis] Equity Component [Domain] Common Stock [Member] Common Stock Common stock Additional Paid-in Capital [Member] Additional paid-in capital Treasury Stocks [Member] Treasury stocks Accumulated Deficit [Member] Accumulated deficit Shares, Outstanding Balance (in shares) Balance (in shares) Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures Stock-based compensation related to stock and options granted to directors and employees Stock Issued During Period, Shares, Share-based Compensation, Net of Forfeitures Stock-based compensation related to stock and options granted to directors and employees (in shares) Represents the information pertaining to issuance under at the market. Issuance Of Shares At The Market Issuance of shares in at-the-market (ATM) offering (Note 7) Represents the information pertaining to issuance under at the market. Issuance Of Share Value Issuance of shares in at-the-market (ATM) offering (Note 7) (in shares) Number of shares value for private placement. Issuance of shares for private placement value Issuance of shares for private placement (Note 7) Number of shares issued for private placement. Issuance of shares for private placement Issuance of shares for private placement (Note 7) (shares) INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) Net Cash Provided by (Used in) Operating Activities [Abstract] Cash flows used in operating activities: Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Net loss Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to reconcile net loss to net cash used in operating activities: Depreciation Depreciation Stock or Unit Option Plan Expense Stock-based compensation related to options granted to employees and directors Increase (Decrease) in Operating Lease Liability Change in operating lease liability It represents the increase (decrease) during the reporting period in accounts receivable and prepaid expenses. Increase Decrease In Accounts Receivable and Prepaid Expenses Decrease in other accounts receivable and prepaid expenses Increase (Decrease) in Accounts Payable, Trade Increase (decrease) in trade payables Fair Value Adjustment of Warrants Change in fair value of Warrants liability Gain on change in fair value of warrants (Note 6) Increase (Decrease) in Other Accounts Payable and Accrued Liabilities Increase (decrease) in other accounts payable and accrued expenses Net Cash Provided by (Used in) Operating Activities Total net cash used in operating activities Net Cash Provided by (Used in) Investing Activities [Abstract] Cash flows from investing activities: Payments to Acquire Property, Plant, and Equipment Purchase of property and equipment Payments for (Proceeds from) Investments Changes in short-term deposit Net Cash Provided by (Used in) Investing Activities Total net cash provided by (used in) investing activities Net Cash Provided by (Used in) Financing Activities [Abstract] Cash flows from financing activities: Amount of cash inflow from at the market. Proceeds From At The Market Proceeds from issuance of shares in at-the-market (ATM) offering (Note 7) Proceeds from Issuance of Private Placement Proceeds from Issuance of shares for private placement (Note 7) Net Cash Provided by (Used in) Financing Activities Total net cash provided by financing activities Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Increase (decrease) in cash and cash equivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Cash and cash equivalents at end of the period Cash and cash equivalents at the beginning of the period GENERAL Business Description and Basis of Presentation [Text Block] GENERAL BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation and Significant Accounting Policies [Text Block] BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES RESEARCH AND LICENSE AGREEMENT The entire disclosure on research and license agreement entered by the entity. Research and License Agreement [Text Block] RESEARCH AND LICENSE AGREEMENT SHORT TERM DEPOSITS The entire disclosure of the components short-term deposits. Short Term Deposits Disclosure [Text Block] SHORT TERM DEPOSITS LEASES Lessee, Operating Leases [Text Block] LEASES WARRANTS LIABILITY The entire disclosure of warrants liability. Warrants Liability Disclosure [Text Block] WARRANTS LIABILITY STOCK CAPITAL Stockholders' Equity Note Disclosure [Text Block] STOCK CAPITAL FAIR VALUE MEASUREMENT Fair Value Disclosures [Text Block] FAIR VALUE MEASUREMENT SUBSEQUENT EVENTS Subsequent Events [Text Block] SUBSEQUENT EVENTS Disclosure of accounting policy pertaining to unaudited interim financial statements. Unaudited Interim Financial Statements Policy [Policy Text Block] Unaudited Interim Financial Statements Significant Accounting Policies [Text Block] Significant Accounting Policies New Accounting Pronouncements, Policy [Policy Text Block] Recent Accounting Standards Use of Estimates, Policy [Policy Text Block] Use of estimates Lease, Cost [Table Text Block] Schedule of supplemental cash flow information related to operating leases Lessee, Operating Lease, Liability, Maturity [Table Text Block] Schedule of future lease payments under operating leases Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Schedule of fair value assumptions used for the stock options granted Share-based Compensation, Stock Options, Activity [Table Text Block] Summary of the Company's option activity Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity [Table Text Block] Schedule of compensation expense for restricted stock is based on fair market value at the grant date Tabular disclosure includes the number and weighted-average issue prices for warrants issued to services providers that were outstanding at the beginning and end of the year, and issued during the year. Schedule Stock Awards Activity Related To Service Providers [Table Text Block] Schedule of total stock-based compensation expense Fair Value Measurement Inputs and Valuation Techniques [Table Text Block] Schedule of assumptions used to determine fair value of July 2023 warrants Represents the percentage of all net sales royalty that the company will pay if the making, producing, manufacturing, using, marketing, selling, importing or exporting of such licensed product is covered by a valid claim or is covered by orphan drug status. Percentage of Royalty Payment if Licensed Product Covered by Valid Claim or Orphan Drug Status Percentage of royalty payment if licensed product covered by valid claim or orphan drug status Represents the percentage of all net sales royalty that the company will pay if the making, producing, manufacturing, using, marketing, selling, importing or exporting of such licensed product is not covered by a valid claim or is not covered by orphan drug status. Percentage of Royalty Payment If Licensed Product Not Covered by Valid Claim or Orphan Drug Status Percentage of royalty payment if licensed product not covered by valid claim or orphan drug status This element represents the validity of the royalties' payments by the company not covered by a Valid Claim or Orphan Drug Status in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Validity of Royalty Payment Not Covered by Valid Claim or Orphan Drug Status Validity of royalty payment not covered by valid claim or orphan drug status Tabular disclosure of short term deposits. Schedule of Short Term Deposits [Table] Statistical Measurement [Axis] Statistical Measurement [Domain] Minimum [Member] Minimum Maximum [Member] Maximum Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Short Term Deposits [Line Items] SHORT TERM DEPOSITS Investment Interest Rate Annual interest rate on bank deposits Lessee, Lease, Description [Table] Lessee, Lease, Description [Line Items] LEASES Operating Lease, Liability Operating lease liability Total lease liability balance Operating Lease, Weighted Average Remaining Lease Term Operating lease, weighted average remaining lease term Operating Lease, Weighted Average Discount Rate, Percent Operating lease, weighted average discount rate percent Operating Lease, Payments Cash payments for operating leases Lessee, Operating Lease, Liability, to be Paid, Year One 2023 Lessee, Operating Lease, Liability, to be Paid, Year Two 2024 Lessee, Operating Lease, Liability, to be Paid, Year Three 2025 Lessee, Operating Lease, Liability, to be Paid, Year Four 2026 Lessee, Operating Lease, Liability, to be Paid Total future lease payments Lessee, Operating Lease, Liability, Undiscounted Excess Amount Less imputed interest Class of Warrant or Right [Table] Warrant [Member] Private placement warrants Class of Warrant or Right [Axis] Class of Warrant or Right [Domain] Represents the information pertaining to July 2023 warrants. July 2023 Warrants [Member] July 2023 warrants Class of Warrant or Right [Line Items] WARRANTS LIABILITY Stock Issued During Period, Shares, New Issues Aggregate shares sold Class of Warrant or Right, Number of Securities Called by Warrants or Rights Class of Warrant or Right, Number of Securities Called by Warrants or Rights Warrants to purchase shares of common stock The cash inflow associated with the amount received from issuance of common stock and from holders exercising their stock warrants. Proceeds from Issuance of Common Stock and Warrants Exercises Gross proceeds The carrying amount of issuance costs related to warrants liability and equity. Warrants Liability and Equity, Issuance Costs Total issuance costs The carrying amount of issuance costs related to warrants liability. Warrant Liability, Issuance Costs Total issuance costs allocated to warrants liability The carrying amount of issuance costs related to equity. Equity, Issuance Costs Total issuance costs allocated to equity Liabilities, Fair Value Disclosure Fair value of warrants Warrants and Rights Outstanding Warrants outstanding Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Sale of Stock [Axis] Sale of Stock [Domain] This member represents at market offering. At Market Offering [Member] At Market Offering Option Indexed to Issuer's Equity, Type [Axis] Option Indexed to Issuer's Equity, Type [Domain] This member stands for Global Share Option Plan 2014 And US Stock Option And Incentive Plan 2014. Global Share Option Plan 2014 And US Stock Option And Incentive Plan 2014 [Member] Global Share Option Plan 2014 And US Stock Option And Incentive Plan 2014 Award Type [Axis] Equity Award [Domain] Share-Based Payment Arrangement, Option [Member] Employee Stock Option Restricted Stock [Member] Restricted Stock Share-based Compensation Arrangement by Share-based Payment Award [Line Items] STOCK CAPITAL Stock Issued During Period, Value, New Issues Aggregate offering amount Proceeds from Issuance of Common Stock Gross proceeds Stock Issued During Period, Shares, Issued for Services Issuance of common stock Common Stock, Capital Shares Reserved for Future Issuance Future issuance of common stock Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Unrecognized compensation cost Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Weighted average period Share-based Compensation Compensation expense (income) Total stock-based compensation expense Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Represents the information pertaining to securities purchase agreement. Securities Purchase Agreement [Member] Securities purchase agreement Represents the information pertaining to public offering. Public Offering [Member] Public offering Shares Issued, Price Per Share Purchase price per share Proceeds from Issuance or Sale of Equity Gross proceeds Warrants and Rights Outstanding, Term Warrants term Class of Warrant or Right, Exercise price Class of warrant exercise price Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period Option life (years) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum Risk-free interest, Minimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum Risk-free interest, Maximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate Dividend yield Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum Expected volatility, Minimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum Expected volatility, Maximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term Expected life of up to (years) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Amount of options, Outstanding at end of period Amount of options, Outstanding at beginning of period Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross Amount of options, Granted Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period Amount of options, Forfeited Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number Amount of options, Exercisable at end of period | shares Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Weighted average exercise price, Outstanding at end of period (in dollars per share) Weighted average exercise price, Outstanding at beginning of period (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Weighted average exercise price, Granted (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Weighted Average exercise Price, Forfeited (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Weighted average exercise price, Exercisable at end of period (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number Number of Shares of Restricted Stock, Nonvested at end of period Number of Shares of Restricted Stock, Nonvested at beginning of period Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period Granted Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period Vested Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period Forfeited Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Weighted Average Grant Date Fair Value, Nonvested at end of period Weighted Average Grant Date Fair Value, Nonvested at beginning of period Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Granted Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Vested Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Forfeited Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms Weighted Average Remaining Contractual Term (Years), Nonvested Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table] Income Statement Location [Axis] Income Statement Location [Domain] Research and Development Expense [Member] Research and development General and Administrative Expense [Member] General and administrative Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] STOCK CAPITAL Fair Value Measurement Inputs and Valuation Techniques [Table] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Domain] Fair Value, Inputs, Level 3 [Member] Level 3 Measurement Input Type [Axis] Measurement Input Type [Domain] Measurement Input, Maturity [Member] Time to expiration Measurement Input, Share Price [Member] Common stock price Measurement Input, Risk Free Interest Rate [Member] Risk-free interest rate Measurement Input, Price Volatility [Member] Volatility Fair Value Measurement Inputs and Valuation Techniques [Line Items] Assumptions used to determine fair value of warrants Warrants and Rights Outstanding, Measurement Input Warrants liabilities, inputs Subsequent Event [Table] Subsequent Event Type [Axis] Subsequent Event Type [Domain] Subsequent Event [Member] Subsequent Event Subsequent Event SUBSEQUENT EVENTS The percentage of targeted reduction in headcount. Percentage of Targeted Reduction in Headcount Percentage of targeted reduction in headcount